Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 17;17(1):25.
doi: 10.1186/s12974-020-1705-z.

The progress of gut microbiome research related to brain disorders

Affiliations
Review

The progress of gut microbiome research related to brain disorders

Sibo Zhu et al. J Neuroinflammation. .

Abstract

There is increasing evidence showing that the dynamic changes in the gut microbiota can alter brain physiology and behavior. Cognition was originally thought to be regulated only by the central nervous system. However, it is now becoming clear that many non-nervous system factors, including the gut-resident bacteria of the gastrointestinal tract, regulate and influence cognitive dysfunction as well as the process of neurodegeneration and cerebrovascular diseases. Extrinsic and intrinsic factors including dietary habits can regulate the composition of the microbiota. Microbes release metabolites and microbiota-derived molecules to further trigger host-derived cytokines and inflammation in the central nervous system, which contribute greatly to the pathogenesis of host brain disorders such as pain, depression, anxiety, autism, Alzheimer's diseases, Parkinson's disease, and stroke. Change of blood-brain barrier permeability, brain vascular physiology, and brain structure are among the most critical causes of the development of downstream neurological dysfunction. In this review, we will discuss the following parts: Overview of technical approaches used in gut microbiome studiesMicrobiota and immunityGut microbiota and metabolitesMicrobiota-induced blood-brain barrier dysfunctionNeuropsychiatric diseases ■ Stress and depression■ Pain and migraine■ Autism spectrum disordersNeurodegenerative diseases ■ Parkinson's disease■ Alzheimer's disease■ Amyotrophic lateral sclerosis■ Multiple sclerosisCerebrovascular disease ■ Atherosclerosis■ Stroke■ Arteriovenous malformationConclusions and perspectives.

Keywords: Cerebrovascular diseases; Gut microbiome; Metabolite; Neurodegenerative disorders; Neuropsychiatric disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declared no competing interests.

Figures

Fig. 1
Fig. 1
Dysregulation of the gut microbiota in brain disorders. Extrinsic and intrinsic factors shape the composition of gut microbiota and further contribute to brain disorders, including cognitive dysfunction, neurodegeneration, and cerebrovascular diseases
Fig. 2
Fig. 2
Dietary metabolism and roles of the gut microbiota. Dietary habit and food pattern result in the formation of gut microbiota and in turn modulate the host inflammation and thrombosis, by which the brain disorders are induced

References

    1. Madigan MT. Brock biology of microorganisms. 13. San Francisco: Benjamin Cummings; 2012.
    1. Shulman ST, Friedmann HC, Sims RH. Theodor Escherich: the first pediatric infectious diseases physician? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;45(8):1025–1029. doi: 10.1086/521946. - DOI - PubMed
    1. Podolsky SH. Metchnikoff and the microbiome. Lancet. 2012;380(9856):1810–1811. doi: 10.1016/S0140-6736(12)62018-2. - DOI - PubMed
    1. Tirosh I, Izar B, Prakadan SM, Wadsworth MH, 2nd, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189–196. doi: 10.1126/science.aad0501. - DOI - PMC - PubMed
    1. Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, Thiery JP. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO molecular medicine. 2014;6(10):1279–1293. doi: 10.15252/emmm.201404208. - DOI - PMC - PubMed